🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
In this study, investigators utilize a radiopathomics integrated Artificial...
Status
Unknown
Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06396143
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-06-29
Trial ID
NCT07582315
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested
The purpose of this trial is to investigate the efficacy of cetuximab in co...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00122460
The primary purpose of this study is to help answer the following research ...
Status
Completed
Location
Highlands Oncology Group
Start Date
2010-04
Trial ID
NCT01099358
Treatments Being Tested
The purpose of this study is to determine the safety and maximum tolerated ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
1997-10
Trial ID
NCT00139243
Treatments Being Tested
The primary objective of this study is to determine the response rate, tole...
Status
Unknown
Location
Department of Radiation Oncology, Cancer Hospital, Fudan University
Start Date
2009-01
Trial ID
NCT00817583
Study objectives: To determine Ro resection rate of Docetaxel, cisplatin a...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-06
Trial ID
NCT00343239
Treatments Being Tested
The purpose of this study is to preliminarily observe the efficacy and safe...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06391905